Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tocopherol + clobetasol propionate + salicylic acid + panthenol is a topical compounded formulation containing a combination of the antioxidant tocopherol (vitamin E), the high-potency corticosteroid clobetasol propionate, the keratolytic agent salicylic acid, and the humectant/emollient panthenol (provitamin B5). This compounded mixture is used topically to treat nail disorders, such as nail dystrophy and discoloration associated with Yellow Nail Syndrome (YNS). Clobetasol propionate acts as an anti-inflammatory agent, salicylic acid helps soften and exfoliate the nail plate to improve drug penetration, tocopherol provides antioxidant protection and supports nail health, and panthenol acts as a moisturizing agent to improve nail hydration and flexibility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tocopherol + clobetasol propionate + salicylic acid + panthenol.